Bladder Cancer Clinical Trials in San Francisco, California
11 recruitingSan Francisco, California
Showing 1–11 of 11 trials
Recruiting
Phase 2Phase 3
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial CancerBladder Cancer
Daiichi Sankyo630 enrolled79 locationsNCT07129993
Recruiting
Phase 1Phase 2
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Bladder Cancer
Merck Sharp & Dohme LLC55 enrolled9 locationsNCT07232602
Recruiting
Phase 1Phase 2
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Muscle-Invasive Bladder CarcinomaBladder CancerStage II Bladder Cancer AJCC v8+1 more
University of California, San Francisco47 enrolled1 locationNCT06470282
Recruiting
Phase 1
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Breast CancerOvarian CancerProstate Cancer+8 more
Clasp Therapeutics, Inc.90 enrolled21 locationsNCT06778863
Recruiting
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
Bladder Cancer
Cedars-Sinai Medical Center300 enrolled4 locationsNCT03193515
Recruiting
Predicting BCG Response
Bladder Cancer
Cedars-Sinai Medical Center400 enrolled5 locationsNCT04564781
Recruiting
Blue Light Cystoscopy With Cysview® Registry
Bladder Cancer
Photocure4,400 enrolled23 locationsNCT02660645
Recruiting
Measuring Surgical Recovery After Radical Cystectomy
Bladder Cancer
M.D. Anderson Cancer Center2,000 enrolled11 locationsNCT03193970
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Not Applicable
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
Breast CancerOvarian CancerEndometrial Cancer+6 more
University of California, San Francisco1,000 enrolled1 locationNCT05056077
Recruiting
Phase 1Phase 2
A Beta-only IL-2 ImmunoTherapY Study
Triple-Negative Breast CancerEsophageal CancerGastric Cancer+34 more
Medicenna Therapeutics, Inc.115 enrolled27 locationsNCT05086692